CE17 - Recherche translationnelle en santé

PET-MR imaging of an animal model of multiple sclerosis: evaluation of new radiotracers for myelin – Myelin-Imaging

Submission summary

Multiple sclerosis is the prototype autoimmune disorder of the central nervous system. Effective therapies to reverse neuronal damage and restore function are a major unmet need. New drugs that promote the formation of myelin may be effective in reducing long-term disability. An associated imaging method of brain white matter is eagerly needed to evaluate these potential treatments. This could add predictive value to current management of patients with Magnetic Resonance Imaging (MRI).
Positron Emission Tomography (PET) is a nuclear medicine technique consisting in the injection of a radiolabeled probe. The main objective of the current proposal is to evaluate such myelin radiotracers comparatively to advanced MRI techniques in a primate model of multiple sclerosis. This short-term study in animals will prepare a clinical trial in patients by providing key information that would hardly be gathered in humans (or at the price of an increased exposition to medical radioactivity).

Project coordination

Fabien CHAUVEAU (Centre de Recherche en Neurosciences de Lyon)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.


CRNL Centre de Recherche en Neurosciences de Lyon

Help of the ANR 283,910 euros
Beginning and duration of the scientific project: - 24 Months

Useful links

Explorez notre base de projets financés



ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter